Clinical Trial Update: Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating pembrolizumab with ferumoxytol-enhanced MRI in patients with non-small cell lung cancer and brain metastases; study terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Lung Carcinoma Metastatic in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7 | Phase 2 | Status: TERMINATED | Results posted: 2022-08-10